Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Sofosbuvir/Velpatasvir for 12 Weeks Is Safe and...
Conference

Sofosbuvir/Velpatasvir for 12 Weeks Is Safe and Effective in Patients Undergoing Dialysis

Authors

Borgia SM; Dearden J; Lurie Y; Shafran SD; Brown A; Hyland R; Lu S; Markova S; Dvory-Sobol H; Osinusi AO

Volume

68

Pagination

pp. 1456A-1456A

Publisher

WILEY

Publication Date

December 1, 2018

Name of conference

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting

Conference place

Washington, DC

Conference start date

October 20, 2017

Conference end date

October 24, 2017

Conference proceedings

HEPATOLOGY

Issue

6

ISSN

0270-9139

Labels